Exploring the Hallmarks of Cancer With Real-Time Live-Cell Analysis

March 11, 2019

Our understanding of tumor biology is constantly evolving and helps to shed new light on the behavior of many cancers as well as providing new pharmacological targets and treatment strategies. Over the past decade, there have been immense technological advances in the field of in vitro translational models and live-cell assays.

Spotlight

Technical Resources International Inc.

Founded in 1979, Technical Resources International, Incorporated (TRI) is a certified Hispanic woman-owned full service contract research organization plus (CRO+). We provide product development support services to the global drug, biologic, vaccine, medical device, and health sector communities through the effective combination of scientific, clinical, information technology, and communication services.

OTHER WHITEPAPERS
news image

BUILDING RESILIENT SUPPLY CHAINS REVITALIZING AMERICAN MANUFACTURING AND FOSTERING BROAD-BASED GROWTH

whitePaper | February 24, 2022

The COVID-19 pandemic and resulting economic dislocation revealed long-standing vulnerabilities in our supply chains. The pandemic’s drastic impacts on demand patterns for a range of medical products including essential medicines wreaked havoc on the U.S. healthcare system.

Read More
news image

Paving the way for pharma R&D to use FAIR data

whitePaper | December 16, 2019

The use of FAIR (Findable, Accessible, Interoperable and Reusable) data in drug discovery and development could be transformational. But the pharma industry has been slow to embrace FAIR data — partially because of difficulties in establishing the necessary infrastructure and because of internal culture.

Read More
news image

Research and Development in the Pharmaceutical Industry

whitePaper | April 1, 2021

Every year, the U.S. pharmaceutical industry develops a variety of new drugs that provide valuable medical benefits. Many of those drugs are expensive and contribute to rising health care costs for the private sector and the federal government. Policymakers have considered policies that would lower drug prices and reduce federal drug expenditures. Such policies would probably reduce the industry’s incentive to develop new drugs.

Read More
news image

Deck 7 Webinars and Virtual Events

whitePaper | January 1, 2020

If you recognize some of these challenges, download the Deck 7 Webinar & Virtual Events overview to see how we make it easy for busy marketers to run highly successful webinars and virtual events....

Read More
news image

2020 Prescription Drug List

whitePaper | April 7, 2020

The information in this document is designed to help you understand the prescription drug benefits offered under this plan and to compare these benefits to those offered by other plans. Information contained in this summary is designed to help you compare both the value and scope offormulary benefits.

Read More
news image

The Impact of Rising Generic Drug Prices on the U.S. Drug Supply Chain

whitePaper | April 16, 2020

Over the past two years, the pharmacy industry has seen unprecedented increases in the prices of generic drugs, causing unexpected cost increases for payers and consumers, and spurring an investigation by the United States Congress. High generic drug prices have had an adverse effect on almost everyone in the pharmaceutical supply chain. Consumers face higher co-pays and prices and health plans are dealing with higher drug spend. Physicians are finding the need to prescribe alternative drug therapies while dealing with angry patients.

Read More

Spotlight

Technical Resources International Inc.

Founded in 1979, Technical Resources International, Incorporated (TRI) is a certified Hispanic woman-owned full service contract research organization plus (CRO+). We provide product development support services to the global drug, biologic, vaccine, medical device, and health sector communities through the effective combination of scientific, clinical, information technology, and communication services.

Events